Carton1 (Carton1)
Lansoprazole Tablet, Orally Disintegrating, Delayed Release
Product Images NDC 43598-561
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 43598-561). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Dr.reddys Laboratories Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Carton2 (Carton2)
This is a product description of Lansoprazole Delayed-Release Tablets. The tablets contain 30mg of lansoprazole USP and are orally disintegrating. The package of tablets includes 10 packs, each with 0T. The usual recommended dosage and storage information are provided. The text also includes some additional characters and strings, but they do not appear to be relevant or recognizable.*
Figure1 (Figure1)
This is a chart that displays the mean severity of day heartburn by study day for evaluable patients. Patients were categorized as having severe (3), moderate (2), mild (1), or no (0) symptoms. The chart compares the effects of a placebo, 15 mg lansoprazole, and 30 mg lansoprazole. The chart shows the number of days from the start of treatment.*
Figure2 (Figure2)
Logo (Logo)
Structure (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
